Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodBiogen reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 4 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Copyright/Patent/Trademark8/8
- Health Issues8/8
- Medicare/Medicaid8/8
- Pharmacy8/8
- Taxation/Internal Revenue Code8/8
Trade (domestic/foreign) 7 of 8 · Medical/Disease Research/Clinical Labs 6 of 8 · 1 more · Show all 8
- Trade (domestic/foreign)7/8
- Medical/Disease Research/Clinical Labs6/8
- Manufacturing3/8
Bills named in the filings 17 bills, this period
- H.R. 1492 To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.7 filings
- S. 832 EPIC Act of 20257 filings
- H.R. 946 ORPHAN Cures Act4 filings
- S. 864 HELP Copays Act4 filings
- H.R. 1262 Mikaela Naylon Give Kids a Chance Act3 filings
12 more, 7 named in only one filing · Show all 17
- H.R. 3747 Accelerating Access to Dementia and Alzheimer’s Provider Training Act3 filings
- S. 3267 / H.R. 6130 ASAP Act3 filings
- H.R. 4317 PBM Reform Act of 20252 filings
- H.R. 6837 To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes.2 filings
- S. 3345 PBM Price Transparency and Accountability Act2 filings
- H.R. 5539, 118th ORPHAN Cures Act1 filing
- H.R. 830, 118th HELP Copays Act1 filing
- S. 1214, 118th RARE Act1 filing
- S. 1542, 118th DRUG Act1 filing
- S. 1967, 118th PBM Act1 filing
- S. 3558, 118th Prohibiting Foreign Access to American Genetic Information Act of 20241 filing
- H.R. 1 An act to provide for reconciliation pursuant to title II of H. Con. Res. 14. Broad bill1 filing
From the filings
“Issues relating to drug pricing policy. Pharmacy benefit manager legislation related to patient access to therapies. H.R. 1492/S. 832, EPIC Act.”
“Issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment and Lupus. Issues related to the budget and appropriations process”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- CMS
- HHS
- White House Office
- Treasury
- USTR
- EOP
- VA
The House and Senate appear in every quarter; agencies in all 8 quarters.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Biogen, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 60 sitting members of Congress and 1 other candidate in 2025–26.
See every candidate and member Biogen gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in